Gunsik Cho

CEO at Cellweaverse Co., Ltd.

Speaker

Dr. Gunsik Cho is the Founder and CEO of Cellweaverse, a biotechnology company developing sustainable biomaterials through cell culture. He has over 10 years of experience in stem cell biology, organoid research, and technology commercialization. He holds a Ph.D. in Life Sciences from POSTECH, completed postdoctoral research at Johns Hopkins University School of Medicine, and earned an EMBA from KAIST. He previously served as CEO of Oncoclew, leading the company through its acquisition by SG Medical. At Cellweaverse, he leads the development of C-LAL, a cultured horseshoe crab amoebocyte-derived material for endotoxin testing, alongside other biomaterial pipelines.